=================
计算机辅助药物设计
=================


====
论文
====

====
软件
====

====
数据
====

========
视频教程
========

========
重要链接
========

===========
小组成员进入
===========

 

====
Back
====


一般文献 抗病毒药物设计 GPCR受体药物 抗衰老药物设计 抗肿瘤药物设计 慢性病药物设计 人工智能辅助药物设计 老药新用 其它

1. Identification of HSP90 inhibitors as a novel class of senolytics . NATURE COMMUNICATIONS. 2017.9

2. Senolytics improve physical function and increase lifespan in old age. NATURE MEDICINE.2018.8

3. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBIOMEDICINE.2019.9

4. Emerging use of senolytics and senomorphics against aging and chronic diseases.MEDICINAL RESEARCH REVIEWS. 2020.6

5. COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? AGING-US. 2020.4

6. Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice. Cell Metabolism.2020.9 (PDB ID: 1DS1)

 

计算机辅助药物设计

计算机辅助药物设计(computer aided drug design)是以计算化学为基础,通过计算机的模拟、计算和预测药物与受体生物大分子之间的关系,设计和优化先导化合物的方法。计算机辅助药物设计实际上就是通过模拟和计算受体与配体的这种相互作用,进行先导化合物的优化与设计。计算机辅助药物设计包括活性位点分析法、数据库搜寻、全新药物设计等。

上海市浦东新区沪城环路999号